Stocks Briefing
Catalyst Biosciences, Inc. (CBIO) Stock on a Bearish Ride, Here’s the Reason
Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company, has declined 5.74% in aftermarket trading session and consequently is trading at $0.55 at the time of
